Viewing Study NCT02366468


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-02-22 @ 5:14 AM
Study NCT ID: NCT02366468
Status: COMPLETED
Last Update Posted: 2019-01-04
First Post: 2015-01-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CRFB002DDE26
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators